Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Family with Sequence Similarity 164, Member A (FAM164A) (Middle Region) Peptid

FAM164A Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN974305
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 15 bis 21 Werktagen

Kurzübersicht für Family with Sequence Similarity 164, Member A (FAM164A) (Middle Region) Peptid (ABIN974305)

Target

FAM164A (Family with Sequence Similarity 164, Member A (FAM164A))

Spezies

Human

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-C8orf70 antibody (Catalog #: ARP32078_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    FAM164A (Family with Sequence Similarity 164, Member A (FAM164A))

    Hintergrund

    The exact function of FAM164A(C8orf70) remains unknown.

    Alias Symbols: CGI-62, C8orf70, FAM164A

    Protein Size: 325

    Molekulargewicht

    35 kDa

    Gen-ID

    51101

    NCBI Accession

    NM_016010, NP_057094

    UniProt

    Q96GY0
Sie sind hier:
Chat with us!